{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T16:58:09Z","timestamp":1784912289413,"version":"3.55.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,13]],"date-time":"2021-09-13T00:00:00Z","timestamp":1631491200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009019","name":"Shenzhen University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009019","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.intimp.2021.108124","type":"journal-article","created":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T01:50:25Z","timestamp":1632966625000},"page":"108124","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["The increased miRNA-150-5p expression of the tonsil tissue in patients with IgA nephropathy may be related to the pathogenesis of disease"],"prefix":"10.1016","volume":"100","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2561-2615","authenticated-orcid":false,"given":"Yi","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongcheng","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haofei","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiying","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"25","key":"10.1016\/j.intimp.2021.108124_b0005","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1056\/NEJMra1206793","article-title":"IgA nephropathy","volume":"368","author":"Wyatt","year":"2013","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.intimp.2021.108124_b0010","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/nrneph.2015.208","article-title":"The mucosa-kidney axis in IgA nephropathy","volume":"12","author":"Floege","year":"2016","journal-title":"Nat Rev Nephrol"},{"issue":"12","key":"10.1016\/j.intimp.2021.108124_b0015","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.molmed.2015.10.003","article-title":"Molecular Insights into the Pathogenesis of IgA Nephropathy","volume":"21","author":"Robert","year":"2015","journal-title":"Trends Mol Med"},{"issue":"3","key":"10.1016\/j.intimp.2021.108124_b0020","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/ki.1996.396","article-title":"Deficient IgA1 immune response to nasal cholera toxin subunit B in primary IgA nephropathy","volume":"50","author":"de Fijter","year":"1996","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.intimp.2021.108124_b0025","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1159\/000350533","article-title":"Tonsillar CD4+CD25+ regulatory T cells from IgA nephropathy patients have decreased immunosuppressive activity in experimental IgA nephropathy rats","volume":"37","author":"Huang","year":"2013","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.intimp.2021.108124_b0030","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/639074","article-title":"Pathological role of tonsillar B cells in IgA nephropathy","volume":"2011","author":"Suzuki","year":"2011","journal-title":"Clin Dev Immunol"},{"issue":"3","key":"10.1016\/j.intimp.2021.108124_b0035","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.ekir.2017.02.005","article-title":"What Genetics Tells Us About the Pathogenesis of IgA Nephropathy: The Role of Immune Factors and Infection","volume":"2","author":"Zhang","year":"2017","journal-title":"Kidney Int Rep"},{"issue":"5","key":"10.1016\/j.intimp.2021.108124_b0040","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/nrneph.2014.50","article-title":"MicroRNAs in IgA nephropathy","volume":"10","author":"Szeto","year":"2014","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"10.1016\/j.intimp.2021.108124_b0045","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/ckj\/sfx096","article-title":"MicroRNAs: a new avenue to understand, investigate and treat immunoglobulin A nephropathy?","volume":"11","author":"Selvaskandan","year":"2018","journal-title":"Clin Kidney J"},{"issue":"5","key":"10.1016\/j.intimp.2021.108124_b0050","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s10157-013-0906-5","article-title":"A microarray analysis of urinary microRNAs in renal diseases","volume":"18","author":"Konta","year":"2014","journal-title":"Clin Exp Nephrol"},{"issue":"5","key":"10.1016\/j.intimp.2021.108124_b0055","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1159\/000343452","article-title":"Urinary miR-21, miR-29, and miR-93: novel biomarkers of fibrosis","volume":"36","author":"Wang","year":"2012","journal-title":"Am J Nephrol"},{"issue":"4","key":"10.1016\/j.intimp.2021.108124_b0060","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1155\/2011\/304852","article-title":"Elevated levels of miR-146a and miR-155 in kidney biopsy and urine from patients with IgA nephropathy","volume":"30","author":"Wang","year":"2011","journal-title":"Dis Markers"},{"issue":"10","key":"10.1016\/j.intimp.2021.108124_b0065","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1681\/ASN.2006040368","article-title":"Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease","volume":"17","author":"Ma","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.intimp.2021.108124_b0070","doi-asserted-by":"crossref","first-page":"27209","DOI":"10.1038\/srep27209","article-title":"miR-21-5p renal expression is associated with fibrosis and renal survival in patients with IgA nephropathy","volume":"6","author":"Hennino","year":"2016","journal-title":"Sci Rep"},{"issue":"12","key":"10.1016\/j.intimp.2021.108124_b0075","first-page":"5275","article-title":"Reduced mir-29b-3p expression up-regulate CDK6 and contributes to IgA nephropathy","volume":"7","author":"Xing","year":"2014","journal-title":"Int J Clin Exp Med"},{"issue":"10","key":"10.1016\/j.intimp.2021.108124_b0080","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1007\/s00467-014-2818-3","article-title":"Association of miR-146a rs2910164 with childhood IgA nephropathy","volume":"29","author":"Lin","year":"2014","journal-title":"Pediatr Nephrol"},{"issue":"1","key":"10.1016\/j.intimp.2021.108124_b0085","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s12882-017-0482-0","article-title":"Urinary sediment miRNAs reflect tubulointerstitial damage and therapeutic response in IgA nephropathy","volume":"18","author":"Liang","year":"2017","journal-title":"BMC Nephrol"},{"issue":"1","key":"10.1016\/j.intimp.2021.108124_b0090","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.cell.2007.07.021","article-title":"MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb","volume":"131","author":"Xiao","year":"2007","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.intimp.2021.108124_b0095","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.immuni.2014.09.015","article-title":"miR-155 promotes T follicular helper cell accumulation during chronic, low-grade inflammation","volume":"41","author":"Hu","year":"2014","journal-title":"Immunity"},{"issue":"18","key":"10.1016\/j.intimp.2021.108124_b0100","doi-asserted-by":"crossref","first-page":"7407","DOI":"10.1073\/pnas.1221984110","article-title":"Critical role for miR-181a\/b-1 in agonist selection of invariant natural killer T cells","volume":"110","author":"Zietara","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.intimp.2021.108124_b0105","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1080\/03655230410003314","article-title":"IgA nephropathy and tonsils\u2013an approach from the structure of IgA1 produced by tonsillar lymphocytes","volume":"555","author":"Hiki","year":"2004","journal-title":"Acta Otolaryngol Suppl"},{"issue":"10","key":"10.1016\/j.intimp.2021.108124_b0110","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1681\/ASN.2011050464","article-title":"The pathophysiology of IgA nephropathy","volume":"22","author":"Suzuki","year":"2011","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.intimp.2021.108124_b0115","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nrneph.2012.58","article-title":"Pathogenesis of IgA nephropathy","volume":"8","author":"Lai","year":"2012","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"10.1016\/j.intimp.2021.108124_b0120","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/labinvest.2009.118","article-title":"Intrarenal expression of microRNAs in patients with IgA nephropathy","volume":"90","author":"Wang","year":"2010","journal-title":"Lab Invest"},{"issue":"5","key":"10.1016\/j.intimp.2021.108124_b0125","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1681\/ASN.2011060567","article-title":"Abnormal miR-148b expression promotes aberrant glycosylation of IgA1 in IgA nephropathy","volume":"23","author":"Serino","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.intimp.2021.108124_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.febslet.2015.10.033","article-title":"Increased miR-374b promotes cell proliferation and the production of aberrant glycosylated IgA1 in B cells of IgA nephropathy","author":"Hu","year":"2015","journal-title":"FEBS Lett"},{"issue":"5","key":"10.1016\/j.intimp.2021.108124_b0135","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1159\/000430151","article-title":"Proliferation and Cytokine Production of Human Mesangial Cells Stimulated by Secretory IgA Isolated from Patients with IgA Nephropathy","volume":"36","author":"Liang","year":"2015","journal-title":"Cell Physiol Biochem"},{"issue":"7","key":"10.1016\/j.intimp.2021.108124_b0140","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1093\/ndt\/gfv032","article-title":"Role of let-7b in the regulation of N-acetylgalactosaminyltransferase 2 in IgA nephropathy","volume":"30","author":"Serino","year":"2015","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"10.1016\/j.intimp.2021.108124_b0145","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/ki.2015.333","article-title":"In a retrospective international study, circulating miR-148b and let-7b were found to be serum markers for detecting primary IgA nephropathy","volume":"89","author":"Serino","year":"2016","journal-title":"Kidney Int"},{"issue":"10","key":"10.1016\/j.intimp.2021.108124_b0150","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1038\/nm1639","article-title":"Cellular microRNAs contribute to HIV-1 latency in resting primary CD4+ T lymphocytes","volume":"13","author":"Huang","year":"2007","journal-title":"Nat Med"},{"issue":"10","key":"10.1016\/j.intimp.2021.108124_b0155","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1093\/molbev\/msn165","article-title":"c-Myb is an evolutionary conserved miR-150 target and miR-150\/c-Myb interaction is important for embryonic development","volume":"25","author":"Lin","year":"2008","journal-title":"Mol Biol Evol"},{"key":"10.1016\/j.intimp.2021.108124_b0160","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.3389\/fmicb.2016.01274","article-title":"Circulating MicroRNAs: Potential and Emerging Biomarkers for Diagnosis of Human Infectious Diseases","volume":"7","author":"Verma","year":"2016","journal-title":"Front Microbiol"},{"issue":"1","key":"10.1016\/j.intimp.2021.108124_b0165","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/ibd.21691","article-title":"MicroRNAs in inflammatory bowel disease","volume":"18","author":"Pekow","year":"2012","journal-title":"Inflamm Bowel Dis"},{"issue":"3","key":"10.1016\/j.intimp.2021.108124_b0170","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.yexmp.2014.04.009","article-title":"Elevated circulating miR-150 and miR-342-3p in patients with irritable bowel syndrome","volume":"96","author":"Fourie","year":"2014","journal-title":"Exp Mol Pathol"},{"issue":"12","key":"10.1016\/j.intimp.2021.108124_b0175","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1093\/carcin\/bgr223","article-title":"MicroRNA-150 directly targets MUC4 and suppresses growth and malignant behavior of pancreatic cancer cells","volume":"32","author":"Srivastava","year":"2011","journal-title":"Carcinogenesis"},{"issue":"3","key":"10.1016\/j.intimp.2021.108124_b0180","first-page":"747","article-title":"microRNA-150 inhibits human CD133-positive liver cancer stem cells through negative regulation of the transcription factor c-Myb","volume":"40","author":"Zhang","year":"2012","journal-title":"Int J Oncol"},{"issue":"2","key":"10.1016\/j.intimp.2021.108124_b0185","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1159\/000437379","article-title":"MicroRNA-150 Inhibits Cell Invasion and Migration and Is Downregulated in Human Osteosarcoma","volume":"146","author":"Li","year":"2015","journal-title":"Cytogenet Genome Res"},{"issue":"50","key":"10.1016\/j.intimp.2021.108124_b0190","doi-asserted-by":"crossref","first-page":"20182","DOI":"10.1073\/pnas.1311145110","article-title":"Synthesis and delivery of short, noncoding RNA by B lymphocytes","volume":"110","author":"Almanza","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1016\/j.intimp.2021.108124_b0195","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.4049\/jimmunol.1103342","article-title":"MicroRNA miR-150 is involved in Valpha14 invariant NKT cell development and function","volume":"188","author":"Zheng","year":"2012","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.intimp.2021.108124_b0200","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jaci.2013.04.048","article-title":"Antigen-specific, antibody-coated, exosome-like nanovesicles deliver suppressor T-cell microRNA-150 to effector T cells to inhibit contact sensitivity","volume":"132","author":"Bryniarski","year":"2013","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.intimp.2021.108124_b0205","first-page":"37","article-title":"Enhanced generation of reactive oxygen intermediates by suppressor T cell-derived exosome-treated macrophages","volume":"54","author":"Nazimek","year":"2014","journal-title":"Folia Med Cracov"},{"issue":"3","key":"10.1016\/j.intimp.2021.108124_b0210","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.150258","article-title":"TNF-alpha-induced NF-kappaB activation upregulates microRNA-150-3p and inhibits osteogenesis of mesenchymal stem cells by targeting beta-catenin","volume":"6","author":"Wang","year":"2016","journal-title":"Open Biol"},{"key":"10.1016\/j.intimp.2021.108124_b0215","doi-asserted-by":"crossref","first-page":"23498","DOI":"10.1038\/srep23498","article-title":"Selection of urinary sediment miRNAs as specific biomarkers of IgA nephropathy","volume":"6","author":"Duan","year":"2016","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.intimp.2021.108124_b0220","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1139\/gen-2012-0159","article-title":"Genome-wide analysis of microRNAs expression profiling in patients with primary IgA nephropathy","volume":"56","author":"Tan","year":"2013","journal-title":"Genome"},{"key":"10.1016\/j.intimp.2021.108124_b0225","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.990","article-title":"Profiling and initial validation of urinary microRNAs as biomarkers in IgA nephropathy","volume":"3","author":"Wang","year":"2015","journal-title":"PeerJ"},{"key":"10.1016\/j.intimp.2021.108124_b0230","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.gene.2018.01.050","article-title":"Plasma microRNA signature of patients with IgA nephropathy","volume":"649","author":"Wu","year":"2018","journal-title":"Gene"},{"issue":"11","key":"10.1016\/j.intimp.2021.108124_b0235","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0166700","article-title":"Aberrant IgA1 Glycosylation in IgA Nephropathy: A Systematic Review","volume":"11","author":"Sun","year":"2016","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.intimp.2021.108124_b0240","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1186\/s12967-019-2064-3","article-title":"Comprehensive analysis of aberrantly expressed profiles of mRNA and its relationship with serum galactose-deficient IgA1 level in IgA nephropathy","volume":"17","author":"Liu","year":"2019","journal-title":"J Transl Med"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576921007608?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576921007608?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:36:29Z","timestamp":1761586589000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576921007608"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":48,"alternative-id":["S1567576921007608"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2021.108124","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The increased miRNA-150-5p expression of the tonsil tissue in patients with IgA nephropathy may be related to the pathogenesis of disease","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2021.108124","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"108124"}}